Mirae Asset Global Investments Co. Ltd. bought a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 173,735 shares of the semiconductor company's stock, valued at approximately $75,564,000. Mirae Asset Global Investments Co. Ltd. owned about 0.09% of Synopsys at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of SNPS. BlackRock Inc. bought a new stake in shares of Synopsys during the 2nd quarter valued at $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Synopsys in the 2nd quarter worth $747,400,000. Bank of New York Mellon Corp bought a new position in shares of Synopsys in the 2nd quarter worth $692,074,000. Bank of America Corp DE bought a new position in shares of Synopsys in the 2nd quarter worth $539,986,000. Finally, Legal & General Group Plc bought a new position in shares of Synopsys in the 2nd quarter worth $491,923,000. Institutional investors own 85.47% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on the company. Mizuho decreased their price objective on Synopsys from $600.00 to $550.00 and set an "outperform" rating for the company in a research note on Thursday, August 27th. Rosenblatt Securities increased their target price on Synopsys from $575.00 to $620.00 and gave the company a "buy" rating in a research note on Thursday, October 1st. UBS Group set a $570.00 target price on Synopsys in a report on Thursday, August 27th. Zacks Research upgraded Synopsys from a "hold" rating to a "strong-buy" rating in a report on Friday, October 2nd. Finally, Sanford C. Bernstein started coverage on Synopsys in a research report on Friday, September 25th. They set an "outperform" rating for the company. One investment analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Synopsys has a consensus rating of "Moderate Buy" and a consensus price target of $575.00.
View Our Latest Analysis on SNPS
Synopsys Stock Down 4.6%
Shares of SNPS stock opened at $467.61 on Friday. The firm has a fifty day moving average of $437.48 and a 200-day moving average of $443.62. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. Synopsys, Inc. has a 12-month low of $362.55 and a 12-month high of $539.48. The company has a market capitalization of $89.61 billion, a price-to-earnings ratio of 82.62, a P/E/G ratio of 1.90 and a beta of 1.21.
Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating the consensus estimate of $3.67 by $0.24. The business had revenue of $2.48 billion for the quarter, compared to analysts' expectations of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The firm's revenue was up 42.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, equities research analysts predict that Synopsys, Inc. will post 11.01 earnings per share for the current fiscal year.
Synopsys announced that its board has approved a stock buyback plan on Monday, October 5th that permits the company to buy back $1 billion in outstanding shares. This repurchase authorization permits the semiconductor company to repurchase up to 1.1% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board believes its stock is undervalued.
Insider Transactions at Synopsys
In other Synopsys news, CFO Sudhindra Kankanwadi sold 9,170 shares of Synopsys stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total value of $4,585,000.00. Following the sale, the chief financial officer owned 22,717 shares of the company's stock, valued at $11,358,500. This trade represents a 28.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Sassine Ghazi sold 14,604 shares of the business's stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $462.84, for a total value of $6,759,315.36. Following the completion of the sale, the chief executive officer owned 76,865 shares in the company, valued at approximately $35,576,196.60. This trade represents a 15.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 117,163 shares of company stock worth $51,366,457. Company insiders own 0.56% of the company's stock.
Synopsys Profile
(
Free Report)
Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.
The company's products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.
In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.